Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.763 | 0.400 | 1 | 173222336 | intergenic variant | G/A;T | snv |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.880 | 1.000 | 12 | 2009 | 2019 | ||||||||
|
0.851 | 0.240 | 1 | 173257056 | intergenic variant | T/G | snv | 0.29 |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.810 | 1.000 | 4 | 2013 | 2016 | |||||||
|
1.000 | 0.080 | 1 | 173340574 | intergenic variant | A/G;T | snv |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.810 | 1.000 | 1 | 2008 | 2008 | ||||||||
|
1.000 | 0.040 | 1 | 173363490 | non coding transcript exon variant | A/C | snv | 0.79 |
|
Skin and Connective Tissue Diseases | 0.800 | 1.000 | 2 | 2013 | 2019 | |||||||
|
1.000 | 0.120 | 1 | 173380586 | intergenic variant | A/C;G | snv |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.800 | 1.000 | 2 | 2014 | 2019 | ||||||||
|
0.851 | 0.240 | 1 | 173257056 | intergenic variant | T/G | snv | 0.29 |
|
Skin and Connective Tissue Diseases | 0.800 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.827 | 0.200 | 1 | 173266926 | regulatory region variant | A/C | snv | 0.21 |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.720 | 1.000 | 3 | 2012 | 2013 | |||||||
|
0.807 | 0.280 | 1 | 173254724 | regulatory region variant | G/A | snv | 0.46 |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.720 | 1.000 | 3 | 2009 | 2013 | |||||||
|
1.000 | 0.080 | 1 | 173282717 | intergenic variant | A/G | snv | 0.63 |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.700 | 1.000 | 2 | 2015 | 2016 | |||||||
|
1.000 | 0.080 | 1 | 173250332 | intergenic variant | G/T | snv | 0.32 |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||||
|
1.000 | 0.080 | 1 | 173377204 | intergenic variant | C/T | snv | 0.63 |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2015 | 2015 | |||||||
|
1 | 173262759 | intergenic variant | C/T | snv | 0.58 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
1.000 | 0.080 | 1 | 173338762 | intergenic variant | T/C | snv | 0.21 |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.763 | 0.400 | 1 | 173222336 | intergenic variant | G/A;T | snv |
|
Immune System Diseases; Nervous System Diseases | 0.700 | 1.000 | 1 | 2011 | 2011 | ||||||||
|
0.851 | 0.160 | 1 | 173368608 | upstream gene variant | G/A | snv | 0.63 |
|
Musculoskeletal Diseases; Nervous System Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.851 | 0.160 | 1 | 173368608 | upstream gene variant | G/A | snv | 0.63 |
|
Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.851 | 0.160 | 1 | 173368608 | upstream gene variant | G/A | snv | 0.63 |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.851 | 0.160 | 1 | 173368608 | upstream gene variant | G/A | snv | 0.63 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
1.000 | 0.080 | 1 | 173378698 | intergenic variant | G/A;C | snv |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
1.000 | 0.120 | 1 | 173330604 | regulatory region variant | C/T | snv | 6.7E-02 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2015 | 2015 | |||||||
|
1.000 | 0.080 | 1 | 173337507 | intergenic variant | G/A | snv | 0.21 |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.882 | 0.120 | 1 | 173194429 | intron variant | A/G | snv | 0.47 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.882 | 0.120 | 1 | 173194429 | intron variant | A/G | snv | 0.47 |
|
Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.882 | 0.120 | 1 | 173194429 | intron variant | A/G | snv | 0.47 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
1.000 | 0.080 | 1 | 173237158 | regulatory region variant | G/A | snv | 3.0E-02 |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 |